Coronavirus and Ophthalmology Best Practices with Rishi Singh, MD

Article

Rishi Singh, MD, of Cole Eye Institute, discusses steps to take to help prevent the spread of coronavirus in ophthalmology practices.

While most elective procedures have been canceled and many practices have temporarily closed as a result of the coronavirus disease 2019 (COVID-19), many ophthalmology practices find themselves in a unique and difficult situation.

With so many ophthalmic procedures directly tied to a patient’s quality of life, some patients may be reluctant to cancel and delay injections or other procedures that may require a specific treatment interval.

Due to the nature of treating ophthalmic conditions and how they require close contact with patients, our sister publication Ophthalmology Times reached out to Rishi Singh, MD, of the Cole Eye Institute at the Cleveland Clinic, for more perspective on steps to take to protect ophthalmologists and their patients.

Related Videos
Roger Goldberg, MD: Impact of Dual Inhibition on Hard Exudates in DME | Image Credit: Bay Area Retina Associates
Deepayan Kar, PhD, MS: A Virtual Reality Approach to Contrast Sensitivity in AMD | Image Credit: LinkedIn
Dolly Chang, MD, PhD | Image Credit: LinkedIn
Daniel Su, MD: | Image Credit: Retina Vitreous-Associates Medical Group
Daniela Ferrara, MD, PhD: Machine Learning Predicts Functional Outcomes in DME | Image Credit: Ophthalmology Innovation Summit
Ashkan Abbey, MD: 3-Year Efficacy of Pegcetacoplan for Geographic Atrophy | Image Credit: Texas Retina AssociatesImage Credit:
© 2024 MJH Life Sciences

All rights reserved.